Literature DB >> 4166664

Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.

R S Evans, E Turner, M Bingham.   

Abstract

The red cells of patients with chronic hemolytic anemia due to cold agglutinins are agglutinated by antiglobulin serum in a nongamma reaction due to the coating of beta-globulins, C'4 and C'3. The red cells of such patients are abnormally resistant to C' hemolysis by cold agglutinin. Normal red cells can be made equally resistant to C' hemolysis by incubation with cold agglutinin and normal serum at temperatures which allow transient reactions between the red cells and cold agglutinins. The development of resistance to C' hemolysis was related to increasing susceptibility to agglutination in anti-beta(1c)- and anti-beta(1e)-sera and by increasing uptake of (131)I activity from labeled anti-beta-globulin serum containing antibodies for both globulins. There was decrease in the adsorption of (131)I-labeled cold agglutinin during the development of resistance to C' hemolysis and reduced susceptibility to agglutination by cold agglutinins. Since cold agglutinins have been demonstrated to dissociate from the red cell, leaving fractions of C' globulin attached, it is postulated that repeated transient reactions produce the accumulation of incomplete C' complexes. Steric hindrance by the adsorbed C' complexes is probably responsible for the inhibition of the reaction with cold agglutinin. There is evidence that the adsorbed C' complexes also interfere with the hemolytic action of C' even when cold agglutinin has become reattached to the red cells. The accumulation of C' complexes by cold agglutinins appears to be the most important factor in the abnormal resistance to C' hemolysis exhibited by the patient's red cells. Other factors, such as the heterogeneity within a population of normal cells, appear to be of minor significance.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4166664      PMCID: PMC292892          DOI: 10.1172/JCI105638

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  INTERACTIONS BETWEEN 131-I TRACE-LABELLED COLD AGGLUTININ, COMPLEMENT AND RED CELLS.

Authors:  M HARBOE
Journal:  Br J Haematol       Date:  1964-07       Impact factor: 6.998

2.  THE SIGNIFICANCE OF THE ANTIGEN-ANTIBODY COMPLEMENT REACTION. IV. THE TRANSFORMATION OF BETA-1-C-GLOBULIN INTO BETA-1-A-GLOBULIN.

Authors:  K W PONDMAN; F PEETOOM
Journal:  Immunochemistry       Date:  1964-06

3.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

4.  Concerning the mechanism of complement action. V. The early steps in immune hemolysis.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

5.  Differences in the agglutinability of human red cells by the high-titre cold antibodies of acquired haemolytic anaemia.

Authors:  J H CROOKSTON; J V DACIE; V ROSSI
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

6.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

7.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

8.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

9.  THE ACTION OF ENZYMES FROM CLOSTRIDIUM TERTIUM ON THE I ANTIGENIC DETERMINANT OF HUMAN ERYTHROCYTES.

Authors:  D M MARCUS; E A KABAT; R E ROSENFIELD
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

10.  Isolation and characterization of two beta1-glycoproteins of human serum.

Authors:  H J MULLER-EBERHARD; U NILSSON; T ARONSSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  13 in total

1.  Autoimmune haemolytic anaemias. V. studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease.

Authors:  C P Engelfriet; A E Von dem Borne; D Beckers; E Reynierse; J J Van Loghem
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

2.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

3.  Haemolytic anaemia in the rabbit following the injection of human anti-I cold agglutinins.

Authors:  A G Cooper; D L Brown
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

Review 4.  The role of complement in immune clearance of blood cells.

Authors:  U E Nydegger; M D Kazatchkine
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Autoimmune haemolytic anaemias. 3. Preparation and examination of specific antisera against complement components and products, and their use in serological studies.

Authors:  C P Engelfriet; K W Pondman; G Wolters; D Beckers; G Misset-Groenveld; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

6.  Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.

Authors:  A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

7.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.

Authors:  C J Parker; C M Soldato; M J Telen
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.

Authors:  G L Logue; W F Rosse; J P Gockerman
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.

Authors:  J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.